Oxford University Hospitals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Oxford University Hospitals brings 6 presentations to ASH 2026 in New Orleans. Its program centres on lymphoma, myeloma and CLL. Research covers acalabrutinib in older mantle cell lymphoma, CD38 antibody after transplant and MDS progression to acute myeloid leukemia.
| Organization | ASH 2026 Attendance |
|---|---|
Oxford University Hospitals Oxford, United Kingdom | |
NHS teaching hospital trust in Oxford, England, including the John Radcliffe and Churchill hospitals. | Symposium Fri Dec 11 7:00am–10:00am Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention. Oral Sat Dec 12 9:30am–11:00am Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 4:30pm–5:45pm Acquired Methemoglobinemia: Who, Why, and What to Do Exposures that cause acquired methemoglobinemia, such as dapsone, rasburicase, topical anesthetics and recreational nitrites, and how to diagnose and treat it. Oral Mon Dec 14 4:30pm–6:00pm |
Find decision makers at Oxford University Hospitals
Tell us what you sell and we’ll find the people at Oxford University Hospitals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction